Krystal expands commercial gene therapy production
Krystal Biotech on January 24 announced the beginning of construction on its second commercial gene therapy facility in Findlay Township in Pennsylvania. The facility will have the capacity to produce commercial gene therapy medicines for a variety of rare diseases. Read More
Krystal Biotech on January 24 announced the beginning of construction on its second commercial gene therapy facility in Findlay Township in Pennsylvania. The facility will have the capacity to produce commercial gene therapy medicines for a variety of rare diseases. Read More
Agilent unveils SureSelect DNA kit
Agilent Technologies has debuted SureSelect XT HS2, a DNA kit designed to help laboratories prepare DNA sequencing libraries for cancer and genetics research. Read More
Agilent Technologies has debuted SureSelect XT HS2, a DNA kit designed to help laboratories prepare DNA sequencing libraries for cancer and genetics research. Read More
Thermo Fisher launches new compressor-free plate sealer
Thermo Fisher Scientific has released its ALPS 5000 plate sealer and is showing the product at the 2020 Society for Laboratory Automation and Screening meeting in San Diego. Read More
Thermo Fisher Scientific has released its ALPS 5000 plate sealer and is showing the product at the 2020 Society for Laboratory Automation and Screening meeting in San Diego. Read More
Researchers present data on long-term vagus implant in mice
Data from the first successful long-term vagus nerve stimulation implant in a mouse was reported last week at the 2020 North American Neuromodulation Society annual meeting by researchers from the Feinstein Institutes of Medical Research at Northwell Health. The successful implementation of this technology could provide game-changing therapies for multiple chronic diseases. Read More
Data from the first successful long-term vagus nerve stimulation implant in a mouse was reported last week at the 2020 North American Neuromodulation Society annual meeting by researchers from the Feinstein Institutes of Medical Research at Northwell Health. The successful implementation of this technology could provide game-changing therapies for multiple chronic diseases. Read More
Eveotec, Indivumed partner on novel lung cancer therapies
Evotec and Indivumed announced on January 23 a partnership to collaborate on drug discovery and development of novel therapies for non-small cell lung cancer. The goal of the collaboration is to provide highly effective precision medicine treatments for patients. Read More
Evotec and Indivumed announced on January 23 a partnership to collaborate on drug discovery and development of novel therapies for non-small cell lung cancer. The goal of the collaboration is to provide highly effective precision medicine treatments for patients. Read More
HighRes, Novo Nordisk work on robotic drug discovery
Life science robotics company HighRes Biosolutions and global healthcare company Novo Nordisk plan to design a robotic platform for high-throughput biologics engineering and characterization of potential drug discovery candidates. Read More
Life science robotics company HighRes Biosolutions and global healthcare company Novo Nordisk plan to design a robotic platform for high-throughput biologics engineering and characterization of potential drug discovery candidates. Read More
Joint venture targets cell and gene therapy
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint venture is owned equally by three partners: Bio-Techne, Fresenius Kabi, and Wilson Wolf. Read More
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint venture is owned equally by three partners: Bio-Techne, Fresenius Kabi, and Wilson Wolf. Read More
Key CRISPR patent revoked in Europe
An important patent on CRISPR technology held by the Broad Institute has been revoked by the European Patent Office. Read More
An important patent on CRISPR technology held by the Broad Institute has been revoked by the European Patent Office. Read More
LabCorp adopts Thermo Fisher NGS for companion diagnostics
LabCorp announced on January 14 that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine precision assay for use in research and development of companion diagnostics and precision medicine applications. Read More
LabCorp announced on January 14 that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine precision assay for use in research and development of companion diagnostics and precision medicine applications. Read More
Evotec, Bayer partner for drug discovery in women's health
Evotec and Bayer announced on January 9 the expansion of their partnership in women's health with a new five-year, multitarget collaboration with participation from Celmatix to develop multiple clinical candidates for the treatment of polycystic ovary syndrome. Read More
Evotec and Bayer announced on January 9 the expansion of their partnership in women's health with a new five-year, multitarget collaboration with participation from Celmatix to develop multiple clinical candidates for the treatment of polycystic ovary syndrome. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
